• Home
  • Lifetech Products
  • R & D
  • News
  • Investor Relations
  • About Us
中文
  • Company Profile
  • Finanical Report
  • Announcement
  • IR Contact
  • 2022-09-05

    FDA Approved Investigator-initiated Pre-market Clinical Trial of LAmbreTM Plus LAA Closure System Obtained Medical Insurance Coverage in the US

     
  • 2022-09-02

    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2022

     
  • 2022-08-30

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2022

     
  • 2022-08-12

    NOTICE OF BOARD MEETING

     
  • 2022-08-03

    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2022

     
  • 2022-07-20

    CHANGE OF ADDRESS OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE

     
  • 2022-07-05

    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2022

     
  • 2022-06-17

    DISCLOSEABLE TRANSACTION - SUBSCRIPTION OF PRINCIPAL-PROTECTED STRUCTURED DEPOSIT

     
  • 2022-06-07

    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2022 (REVISED)

     
  • 2022-06-07

    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2022

     
  • ←
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • →
Legal Notice|Contact Us||Site Map
-->

Lifetech WeChat

Links

Links...
  • Twitter
  • Linked
  • clhweb
Copyright © 2008-2020 Lifetech Scientific, All rights reserved.